Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Test of Pro-Adrenomedullin for diagnosing acute appendicitis in adults

Official title: Prospective Comparison of the Diagnostic Accuracy of Pro-Adrenomedullin, C-Reactive Protein, and Neutrophil-to-Lymphocyte Ratio in Acute Appendicitis

Run by Bursa Yuksek Ihtisas Training and Research Hospital · NCT07889544 · Data updated 2026-11-12

We are testing whether Pro-Adrenomedullin can help diagnose acute appendicitis in adults and how it compares to CRP and NLR.

More Appendicitis Acute trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment400 (estimated)
SponsorBursa Yuksek Ihtisas Training and Research Hospital
Government
Locations1 site (Bursa)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedAugust 1, 2027
Study endsAugust 1, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07889544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–90 presenting with suspected acute appendicitis and adults without abdominal pain or active inflammatory disease serving as controls.

Probably not a fit

Patients with non-inflammatory abdominal conditions or conditions affecting Pro-ADM could see limited or no diagnostic benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational study at a single center enrolling up to 400 adults (18–90) undergoing appendectomy for acute appendicitis and healthy controls. The study measures Pro-Adrenomedullin levels in blood and compares them with standard inflammatory biomarkers (CRP, NLR) and routine diagnostics. It aims to see how well Pro-ADM distinguishes appendicitis from health and whether it predicts complicated disease. Data collected include medical history, clinical findings, imaging, and laboratory tests. Participants provide informed consent and undergo blood sampling for Pro-ADM along with standard labs.

Why it matters

Potential benefit: If successful, Pro-ADM testing could improve diagnostic accuracy and help identify complicated appendicitis earlier.

How similar studies have gone: Previous research suggests Pro-ADM may be useful in other inflammatory infections, but evidence in adult acute appendicitis is limited and this study adds new data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18 to 90 years.
2. Patients presenting to the emergency department within 48 hours of the onset of abdominal pain, either directly or following referral from another healthcare institution with a diagnosis or suspicion of acute appendicitis.
3. Patients undergoing appendectomy for acute appendicitis (acute appendicitis group).
4. Individuals attending outpatient clinics for routine health evaluations without abdominal pain or active inflammatory disease (control group).
5. Provision of informed consent for participation in the study.

Exclusion Criteria:

1. Age younger than 18 years or older than 90 years.
2. Use of antibiotics or systemic corticosteroids within the preceding month.
3. Active malignancy.
4. Immunosuppressive disease or ongoing immunosuppressive treatment.
5. Abdominal surgery within the preceding three months.
6. Heart failure, renal failure, or liver cirrhosis.
7. Pregnancy or postpartum period.
8. Inability to provide informed consent due to psychiatric disorders.

Where it's running

  • Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Ugur Duman, MD — University of Health Sciences Turkiye, Bursa Yuksek Ihtisas Training and Research Hospital
  • Study coordinator: Ugur Duman, MD
  • Email: ugur.duman@sbu.edu.tr
  • Phone: +905458177971

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.